Virtus ETF Advisers’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,051
| Closed | -$68.7K | – | 299 |
|
|
2024
Q4 | $68.7K | Buy |
4,051
+1,132
| +39% | +$19.2K | 0.03% | 388 |
|
|
2024
Q3 | $67.8K | Buy |
2,919
+54
| +2% | +$1.25K | 0.03% | 430 |
|
|
2024
Q2 | $69.8K | Sell |
2,865
-222
| -7% | -$5.41K | 0.03% | 431 |
|
|
2024
Q1 | $104K | Sell |
3,087
-215
| -7% | -$7.26K | 0.06% | 356 |
|
|
2023
Q4 | $104K | Sell |
3,302
-280
| -8% | -$8.83K | 0.07% | 345 |
|
|
2023
Q3 | $91.5K | Sell |
3,582
-354
| -9% | -$9.05K | 0.06% | 345 |
|
|
2023
Q2 | $113K | Sell |
3,936
-1,431
| -27% | -$41K | 0.07% | 338 |
|
|
2023
Q1 | $129K | Sell |
5,367
-2,064
| -28% | -$49.5K | 0.07% | 324 |
|
|
2022
Q4 | $126K | Sell |
7,431
-661
| -8% | -$11.2K | 0.07% | 402 |
|
|
2022
Q3 | $120K | Buy |
8,092
+53
| +0.7% | +$786 | 0.05% | 398 |
|
|
2022
Q2 | $127K | Buy |
8,039
+3,507
| +77% | +$55.4K | 0.05% | 363 |
|
|
2022
Q1 | $122K | Sell |
4,532
-271
| -6% | -$7.3K | 0.05% | 264 |
|
|
2021
Q4 | $178K | Sell |
4,803
-1,110
| -19% | -$41.1K | 0.07% | 253 |
|
|
2021
Q3 | $283K | Sell |
5,913
-316
| -5% | -$15.1K | 0.12% | 206 |
|
|
2021
Q2 | $211K | Buy |
6,229
+3,444
| +124% | +$117K | 0.09% | 307 |
|
|
2021
Q1 | $115K | Buy |
2,785
+42
| +2% | +$1.73K | 0.05% | 349 |
|
|
2020
Q4 | $119K | Buy |
+2,743
| New | +$119K | 0.05% | 350 |
|